Polycythemia

Polycythemia can arise from a bone marrow disorder or from conditions that push the body to make extra red blood cells, and early symptoms of polycythemia may be mild or absent. In primary polycythemia, an acquired change in a gene called JAK2 often drives the process. Secondary risks include low oxygen from lung disease or sleep apnea, living at high altitude, and smoking or carbon monoxide exposure. Testosterone or other anabolic steroids and EPO medicines can raise levels, and dehydration can make counts look high without a true increase. Doctors distinguish between risk factors you can change and those you can’t.

Genetic risk factors

Genetic causes of polycythemia include both acquired DNA changes in blood-forming cells and rarer inherited variants passed through families. Most people with polycythemia vera have an acquired change in the JAK2 gene, while some families carry inherited changes that push the body to make extra red blood cells. Carrying a genetic change doesn’t guarantee the condition will appear. If doctors suspect genetic causes of polycythemia, they may consider testing guided by your history and lab findings.

• JAK2 mutations: Most people with polycythemia vera carry an acquired change in the JAK2 gene (V617F or exon 12). This mutation arises after birth in bone marrow cells and is not inherited.

• Inherited JAK2 pattern: Certain inherited DNA patterns near JAK2 slightly increase the chance of developing a JAK2 mutation and polycythemia vera. The added risk is modest and these variants do not cause disease on their own.

• EPOR variants: Rare inherited changes in the erythropoietin receptor (EPOR) can cause lifelong overproduction of red blood cells. This condition, sometimes called primary familial and congenital polycythemia, often runs in families.

• Oxygen-sensing genes: Inherited variants in VHL, EGLN1 (PHD2), or EPAS1 (HIF-2α) can misread oxygen levels and drive excess erythropoietin. People with these changes often have high erythropoietin and erythrocytosis from a young age.

• High-affinity hemoglobin: Some hemoglobin variants hold oxygen too tightly, so the body compensates by making more red blood cells. These inherited changes affect the globin genes (HBA or HBB) and often show a family pattern.

• 2,3-BPG deficiency: Rare changes in the BPGM gene lower 2,3-bisphosphoglycerate in red cells, making hemoglobin cling to oxygen. The result is secondary erythrocytosis that can resemble high-affinity hemoglobin conditions.

• EPO gene changes: Very rare inherited changes that increase production of erythropoietin (EPO) can raise red blood cell counts. Families may have several relatives with lifelong erythrocytosis.

• Family history: Having close relatives with erythrocytosis or myeloproliferative neoplasms increases the chance of a genetic form. Patterns across generations can guide testing and counseling.

Transmission

Polycythemia isn’t contagious and can’t be passed through casual contact, food, or the air. Most polycythemia happens because of changes that arise in bone marrow cells after birth, so there is no person-to-person transfer and it usually isn’t passed to children. Rarely, there is genetic transmission of polycythemia: an inherited form can run in families when a gene that controls oxygen sensing or the body’s signal to make red blood cells is altered. In these families, how polycythemia is inherited may look like one affected parent passing it to a child, or more rarely, both parents carrying a hidden change. Secondary polycythemia, caused by low oxygen, smoking, certain medicines, or tumors, also isn’t infectious.

When to test your genes

Consider genetic testing if you’ve had unexplained high red blood cell counts, blood clots at a young age, or symptoms like headaches, itching after a hot shower, or splenomegaly, especially if routine tests suggest polycythemia. It’s also reasonable with a family history of myeloproliferative disease. Testing guides diagnosis, prognosis, and tailored therapy.

Daily routines often adapt as people with polycythemia learn what triggers symptoms and what helps them feel steadier day to day. The outlook is not the same for everyone, but many live for decades with good quality of life when the condition is found early and managed. The main risks come from thicker blood, which can raise the chance of blood clots, strokes, or heart attacks; careful treatment lowers these risks. Doctors call this the prognosis—a medical word for likely outcomes.

Here’s what research and experience suggest about the future. With today’s care—regular phlebotomy, low-dose aspirin when appropriate, and medicines to control blood counts—survival often approaches that of people without polycythemia, especially in those diagnosed younger and without other heart risks. Some people experience early symptoms of polycythemia like headaches, dizziness, itchy skin after a warm shower, or a ruddy complexion, while others notice only abnormal blood test results. A small number may develop complications over time, such as scarring of the bone marrow or transformation to acute leukemia; this is uncommon but more likely after many years or with higher-risk features. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.

Knowing what to expect can ease some of the worry. Mortality is mainly tied to clotting events in untreated or poorly controlled polycythemia; consistent treatment and cardiovascular risk management (blood pressure, cholesterol, stopping smoking) significantly reduce that risk. Genetic testing can sometimes provide more insight into prognosis, helping tailor treatment intensity. Talk with your doctor about what your personal outlook might look like, including your goals, other health conditions, and which warning signs should prompt urgent care.

Polycythemia treatment focuses on safely lowering the number of red blood cells to reduce the risk of clots and ease symptoms like headaches, dizziness, and itching. For many people, treatment begins with small daily steps plus a simple procedure called phlebotomy, where a small amount of blood is removed at intervals to bring hematocrit down to a safer range. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as low‑dose aspirin to reduce clot risk and, in higher‑risk cases, medicines that slow red blood cell production (for example, hydroxyurea or interferon; ruxolitinib may be used if others aren’t suitable). A doctor may adjust your dose to balance benefits and side effects, and you’ll have regular checks of blood counts and iron levels to guide timing of treatments. Alongside medical treatment, lifestyle choices play a role, including staying well hydrated, keeping active, avoiding tobacco, and addressing other clot risks like high blood pressure or high cholesterol.

For most people with polycythemia vera, the gene change that triggers extra red blood cell production is acquired during life and isn’t something you’re born with. Family history is one of the strongest clues to a genetic influence. Rare inherited forms, sometimes called familial or congenital polycythemia, stem from changes in genes that act like a dimmer switch for red cell production, turning it up from birth. These can involve the signal that tells the bone marrow to make red cells, the body’s oxygen‑sensing system, or hemoglobin that holds oxygen more tightly than usual. By contrast, the common JAK2 change found in polycythemia vera arises only in blood-forming cells and is usually not passed on to children. When polycythemia starts early or runs in several relatives, doctors may suggest genetic counseling and, if needed, genetic testing for polycythemia to clarify the cause and tailor care.

Thicker blood in polycythemia can strain the heart and raise the chance of clots, so heart disease, high blood pressure, high cholesterol, diabetes, and smoking-related illness can add to that risk. If someone also has an irregular heartbeat, coronary artery disease, or a past stroke, care teams often balance clot prevention (like low‑dose aspirin or blood thinners) with bleeding risk, especially if there’s a history of stomach ulcers. Sleep apnea and chronic lung disease can drive secondary polycythemia; treating the breathing problem often lowers red cell counts and eases symptoms like headaches or facial flushing. Kidney problems and certain kidney or liver growths can increase a hormone that tells the body to make more red cells, which can worsen polycythemia; doctors may check oxygen levels and look for these triggers. Uric acid can run high in polycythemia, so gout flares are more likely, especially when chronic kidney disease or water tablets are also in the mix. Ask if any medications for one condition might interfere with treatment for another.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.